POTENTIAL PREDICTORS FOR ACHIEVING AND/OR MAINTAINING LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Akkoc, N. [1 ]
Zerbini, C. A. [2 ]
Karateev, D. [3 ]
Pedersen, R. [4 ]
Vlahos, B. [4 ]
Marshall, L. [4 ]
Bao, C. [5 ]
Al-Maini, M. [6 ]
Shen, Q. [4 ]
机构
[1] Dokuz Eylul Univ, Izmir, Turkey
[2] Ctr Paulista Invest Clin, Sao Paulo, Brazil
[3] Inst Rheumatol, Moscow, Russia
[4] Pfizer, Collegeville, PA USA
[5] Ren Ji Hosp, Shanghai, Peoples R China
[6] Mafraq Hosp, Abu Dhabi, U Arab Emirates
关键词
D O I
10.1136/annrheumdis-2016-eular.1856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0065
引用
收藏
页码:201 / 202
页数:2
相关论文
共 50 条
  • [31] LOW DISEASE ACTIVITY OR DAS-REMISSION AS TREATMENT TARGET IN EARLY RHEUMATOID ARTHRITIS PATIENTS
    Akdemir, G.
    Markusse, I. M.
    Schouffoer, A. A.
    de Sonnaville, P. B.
    Grillet, B. A.
    Kerstens, P. J.
    Lems, W. F.
    Huizinga, T. W.
    Allaart, C. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 454 - 454
  • [32] Discontinuation of Biologics in Patients with Rheumatoid Arthritis after Achieving Low-Activity Disease Status
    Ochiai, Moeko
    Sato, Eri
    Tanaka, Eiichi
    Inoue, Eisuke
    Nakajima, Ayako
    Momohara, Shigeki
    Taniguchi, Atsuo
    Yamanaka, Hisashi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S213 - S214
  • [33] Predictors for Remission in Rheumatoid Arthritis Patients: A Systematic Review
    Katchamart, Wanruchada
    Johnson, Sindhu
    Lin, Hsing-Ju Lucy
    Phumethum, Veerapong
    Salliot, Carine
    Bombardier, Claire
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (08) : 1128 - 1143
  • [34] Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
    Schlager, Lukas
    Loiskandl, Michaela
    Aletaha, Daniel
    Radner, Helga
    [J]. RHEUMATOLOGY, 2020, 59 (02) : 324 - 334
  • [35] Ultrasonographic Disease Activity in Rheumatoid Arthritis Patients Who Are in Clinical Remission According to Different Remission Criteria: Should We Insist on Achieving Boolean Remission?
    Ozen, Gulsen
    Unal, Ali Ugur
    Topcu, Atakan
    Atagunduz, Pamir
    Direskeneli, Haner
    Inanc, Nevsun
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [36] Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis
    Aldridge, J.
    Lundell, A-C
    Andersson, K.
    Mark, L.
    Hetland, M. Lund
    Ostergaard, M.
    Uhlig, T.
    Heiberg, M. Schrumpf
    Haavardsholm, E. A.
    Nurmohamed, M.
    Lampa, J.
    Nordstrom, D.
    Horslev-Petersen, K.
    Gudbjornsson, B.
    Grondal, G.
    van Vollenhoven, R.
    Rudin, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (07) : 1393 - 1402
  • [37] Rheumatoid arthritis: goal should be remission or low disease activity, says NICE
    Mayor, Susan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 362 : k3101
  • [38] Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
    Gamboa-Cardenas, Rocio, V
    Ugarte-Gil, Manuel F.
    Loreto, Massardo
    Sacnun, Monica P.
    Saurit, Veronica
    Cardiel, Mario H.
    Soriano, Enrique R.
    Pisoni, Cecilia
    Galarza-Maldonado, Claudio M.
    Rios, Carlos
    Radominski, Sebastiao C.
    Castelar-Pinheiro, Geraldo da R.
    Alves Bianchi, Washington
    Appenzeller, Simone
    Guimaraes da Silveira, Ines
    de Freitas Zerbini, Cristiano A.
    Caballero-Uribe, Carlo, V
    Rojas-Villarraga, Adriana
    Guibert-Toledano, Marlene
    Ballesteros, Francisco
    Montufar, Ruben
    Vazquez-Mellado, Janitzia
    Esquivel-Valerio, Jorge
    Garcia De la Torre, Ignacio
    Barile-Fabris, Leonor A.
    Irazoque Palezuelos, Fedra
    Andrade-Ortega, Lilia
    Monge, Pablo
    Teijeiro, Raquel
    Achurra-Castillo, Angel F.
    Spinetti, Maria H. Esteva
    Alarcon, Graciela S.
    Pons-Estel, Bernardo A.
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (10) : 2737 - 2746
  • [39] Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
    Rocio V Gamboa-Cárdenas
    Manuel F. Ugarte-Gil
    Massardo Loreto
    Mónica P. Sacnun
    Verónica Saurit
    Mario H. Cardiel
    Enrique R. Soriano
    Cecilia Pisoni
    Claudio M. Galarza-Maldonado
    Carlos Rios
    Sebastião C. Radominski
    Geraldo da R. Castelar-Pinheiro
    Washington Alves Bianchi
    Simone Appenzeller
    Inés Guimarães da Silveira
    Cristiano A. de Freitas Zerbini
    Carlo V. Caballero-Uribe
    Adriana Rojas-Villarraga
    Marlene Guibert-Toledano
    Francisco Ballesteros
    Rubén Montufar
    Janitzia Vázquez-Mellado
    Jorge Esquivel-Valerio
    Ignacio García De La Torre
    Leonor A. Barile-Fabris
    Fedra Irazoque Palezuelos
    Lilia Andrade-Ortega
    Pablo Monge
    Raquel Teijeiro
    Ángel F. Achurra-Castillo
    María H. Esteva Spinetti
    Graciela S. Alarcón
    Bernardo A. Pons-Estel
    [J]. Clinical Rheumatology, 2019, 38 : 2737 - 2746
  • [40] Treatment Adjustment Strategy after Achieving Remission or Low Disease Activity in Rheumatoid Arthritis : A Systematic Review and Meta-Analysis.
    Henaux, Sophie
    Barnetche, Thomas
    Witrand, Adeline Ruyssen
    Fautrel, Bruno
    Cantagrel, Alain G.
    Constantin, Arnaud
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1083 - S1083